Scarica l'app Stockscreener
22.77
0.70%
-0.16
Dopo l'orario di chiusura:
22.77
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DOCS Giù?
Forum
Previsione
Precedente Chiudi:
$22.93
Aprire:
$22.62
Volume 24 ore:
2.40M
Relative Volume:
0.70
Capitalizzazione di mercato:
$4.21B
Reddito:
$637.78M
Utile/perdita netta:
$239.40M
Rapporto P/E:
19.12
EPS:
1.1909
Flusso di cassa netto:
$307.21M
1 W Prestazione:
-6.33%
1M Prestazione:
-11.40%
6M Prestazione:
-68.37%
1 anno Prestazione:
-60.71%
Intervallo 1D:
$21.88
$23.12
Intervallo di 1 settimana:
$21.82
$24.44
Portata 52W:
$21.82
$76.51
Doximity Inc Stock (DOCS) Company Profile
Nome
Doximity Inc
Settore
Industria
Telefono
(650) 549-4330
Indirizzo
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, TEM, BTSG, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
22.77 | 4.21B | 637.78M | 239.40M | 307.21M | 1.1909 |
VEEV
Veeva Systems Inc
|
173.98 | 28.42B | 3.20B | 908.91M | 1.39B | 5.4168 |
TEM
Tempus Ai Inc
|
47.39 | 8.47B | 1.27B | -245.03M | -245.36M | -1.4071 |
BTSG
Brightspring Health Services Inc
|
43.10 | 8.28B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
84.67 | 7.15B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
23.74 | 4.55B | 1.10B | 112.09M | 283.19M | 0.6096 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-01-08 | Aggiornamento | Truist | Hold → Buy |
| 2025-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-10-27 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-10-10 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Downgrade | Goldman | Neutral → Sell |
| 2025-07-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-02-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Neutral |
| 2024-11-14 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-18 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2024-01-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-08-09 | Downgrade | Needham | Buy → Hold |
| 2023-08-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Iniziato | Wells Fargo | Overweight |
| 2022-10-24 | Iniziato | Evercore ISI | In-line |
| 2022-10-13 | Iniziato | BTIG Research | Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Iniziato | Berenberg | Buy |
| 2022-05-18 | Reiterato | BofA Securities | Neutral |
| 2022-05-18 | Reiterato | Goldman | Buy |
| 2022-05-18 | Reiterato | Guggenheim | Buy |
| 2022-05-18 | Reiterato | Jefferies | Buy |
| 2022-05-18 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Reiterato | Needham | Buy |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-04 | Iniziato | BofA Securities | Neutral |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-17 | Iniziato | Robert W. Baird | Outperform |
| 2021-11-10 | Reiterato | Canaccord Genuity | Buy |
| 2021-11-10 | Reiterato | Goldman | Neutral |
| 2021-11-10 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Reiterato | Needham | Buy |
| 2021-11-10 | Reiterato | Piper Sandler | Overweight |
| 2021-08-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-19 | Iniziato | Goldman | Neutral |
| 2021-07-19 | Iniziato | JP Morgan | Overweight |
| 2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Iniziato | Piper Sandler | Overweight |
| 2021-07-19 | Iniziato | Raymond James | Outperform |
| 2021-07-19 | Iniziato | SVB Leerink | Outperform |
| 2021-07-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Doximity Inc Borsa (DOCS) Ultime notizie
Doximity IPO: Everything you need to know about Doximit - FOREX.com
Doximity, Inc. (DOCS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Doximity Sits 70% Below Its 52-Week High With 300,000 AI Users and Zero AI Revenue - TIKR.com
Doximity Analyst Ratings and Price Targets | NYSE:DOCS - Benzinga
DOCS PE Ratio & Valuation, Is DOCS Overvalued - Intellectia AI
TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now? - The Globe and Mail
Doximity (NYSE:DOCS) Reaches New 12-Month LowWhat's Next? - marketbeat.com
Doximity, Inc. Stock Hits New 52-Week Low at $23.14 - Markets Mojo
Has Doximity (DOCS) Become Attractive After Its Sharp Share Price Pullback? - Yahoo Finance
Does Doximity’s (DOCS) Scale With Physicians and Cash Flow Redefine Its Healthcare Tech Moat? - simplywall.st
DOCS Technical Analysis & Stock Price Forecast - Intellectia AI
HIMS vs. DOCS: Which digital health stock offers better upside now? - MSN
Doximity downgraded at J.P. Morgan on valuation and advertising concerns - MSN
Fort Washington Investment Advisors Inc. OH Purchases 231,790 Shares of Doximity, Inc. $DOCS - marketbeat.com
Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Freedom Capital initiates Doximity (DOCS) with buy rating, $31 price target - msn.com
Doximity $31 Million Securities Class Action Settlement - Claim Depot
Vanguard reorganizes reporting; affiliates to report DOCS holdings (DOCS) - Stock Titan
Doximity Declines 4.4% in a Month: How to Play the Stock Now? - msn.com
Doximity, Inc. (NYSE:DOCS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Doximity, Inc. (DOCS) Stock Forecasts - Yahoo Finance
Fidelity Trend Fund's Doximity Inc(DOCS) Holding History - GuruFocus
Doximity (NYSE:DOCS) Hits New 1-Year LowTime to Sell? - MarketBeat
HIMS or DOCS: Which Digital Health Company Has Greater Growth Potential Today? - Bitget
Doximity stock hits 52-week low at 23.53 USD By Investing.com - Investing.com South Africa
HIMS vs. DOCS: Which Digital Health Stock Offers Better Upside Now? - The Globe and Mail
Doximity stock hits 52-week low at 23.53 USD - Investing.com
E. Ohman J or Asset Management AB Invests $24.70 Million in Doximity, Inc. $DOCS - MarketBeat
Hims & Hers Expands Integrated Digital Healthcare Ecosystem - TradingView
Freedom Capital Initiates Doximity (DOCS) With Buy Rating, $31 Price Target - Insider Monkey
Doximity Inc. (NYSE:DOCS) Presents a Compelling Case for Growth at a Reasonable Price (GARP) Investors - ChartMill
Doximity (NYSE:DOCS) Upgraded to "Strong-Buy" at Freedom Capital - MarketBeat
The Bull Case For Doximity (DOCS) Could Change Following Surge In Physician AI Interest And Concerns - sahmcapital.com
Doximity (DOCS) Receives "Buy" Rating from Freedom Capital Marke - GuruFocus
Analysts Offer Insights on Healthcare Companies: Canopy Growth (CGC) and Doximity (DOCS) - The Globe and Mail
Raymond James sees ‘knee-jerk’ AI reaction, reaffirms strong buy on Doximity, Inc. (DOCS) - MSN
Physicians still concerned about AI accuracy amid rapid adoption: survey - Healthcare Dive
Doximity stock is collapsing after hours: Here's why - MSN
A Look At Doximity’s Valuation After New Report On Rapid Physician AI Adoption - simplywall.st
Freedom Capital Markets initiates Doximity stock with buy rating By Investing.com - Investing.com Australia
Freedom Capital Markets initiates Doximity stock with buy rating - Investing.com
SEC files settled insider trading charges against former Chief Revenue Officer of Doximity - fxnewsgroup.com
Doximity Study Finds Physicians Rapidly Adopting AI, But Accuracy Concerns Persist - The AI Journal
Aquatic Capital Management Buys Doximity Shares - National Today
SEC Sues Ex-Doximity Exec Who Pleaded Guilty to Insider Trading - Bloomberg Law News
Iron Triangle Partners LP Sells 261,300 Shares of Doximity, Inc. - National Today
Doximity Inc Azioni (DOCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.25%
1.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):